Analyst Ratings for DiaMedica Therapeutics Inc. (DMAC)
DMAC Rating Summary
DMAC Price Target Summary
- Highest: $25.00 (Cantor Fitzgerald)
- Lowest: $11.00 (Craig-Hallum)
- Average: $15.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.50 (+101%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$15.50 (+101%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2025 | Cantor Fitzgerald » Updated 1/22/2026 |
Josh Schimmer | New Coverage | Overweight (N/A) |
25.00 (N/A) |
5.42 (7.71) |
42.25% | Details |
| 10/30/2025 | TD Cowen | Stacy Ku | New Coverage | Buy (N/A) |
N/A (N/A) |
6.69 (7.71) |
15.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
